Lavipharm S.A. PEG Ratio

Lavipharm S.A. (LAVI.AT) currently reports a PEG ratio of -534.59. That is below the sector sector average of 10.05. Use the charts on this page to explore Lavipharm S.A.'s PEG ratio history and peer comparisons.

Lavipharm S.A.'s PEG ratio of -534.59 is lower than the its sector sector average of 10.05. That is roughly 5416.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Lavipharm S.A.'s market price to a fundamental measure such as earnings, sales, or book value. At -534.59, LAVI.AT can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -534.59, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.05. From there, open related valuation or income-statement pages for Lavipharm S.A., and consider following LAVI.AT for alerts when major investors trade the stock.